SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-20-052759
Filing Date
2020-04-29
Accepted
2020-04-29 06:41:44
Documents
5
Effectiveness Date
2020-04-29

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm2015741d3_defa14a.htm DEFA14A 20950
2 GRAPHIC image_001.jpg GRAPHIC 62555
3 GRAPHIC image_002.jpg GRAPHIC 109140
4 GRAPHIC image_003.jpg GRAPHIC 28735
5 GRAPHIC image_004.jpg GRAPHIC 11262
  Complete submission text file 0001104659-20-052759.txt   313961
Mailing Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017 813-766-9539
EYENOVIA, INC. (Filer) CIK: 0001682639 (see all company filings)

IRS No.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38365 | Film No.: 20827236
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences